2025 22nd Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production

'The 2025 22nd Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production' is the most comprehensive, longest-running study of bioprocessing professionals. THIS YEAR, the 22nd Annual Report provides Key Takeaways for every chapter highlighting top trends, insights, and opportunities.

• 203 Biopharma companies surveyed
• 116 industry vendors and direct suppliers of materials
• 21 Countries represented
• ~550 Pages
• 12 Chapters
• 200+ Graphs and 20+ Tables
• Subject Matter Experts providing analysis
• Independent Sponsoring Organizations

Highlights

NEW! This year's edition provides additional Subject Matter Experts providing analysis on trends and future growth, and key takeaways for each chapter! This report's 550+ pages of data-rich analysis will help improve your decision making in biomanufacturing operations, with an in-depth analysis of capacity, production trends, benchmarks, and much more.

Coverage - Compare 203 Biomanufacturers vs CMOs; U.S. vs. European & Global Biomanufacturing

• Comprehensive overview of biopharmaceutical manufacturing industry trends, technologies, and challenges
• Industry budget trends and impact of the current economic environment
• Downstream purification problems and issues
• Current and projected biopharmaceutical industry bottlenecks
• Capacity utilization and current production levels
• Capacity bottlenecks - what's being done to resolve
• Biopharma production trends and Outsourcing trends
• International offshoring through 2030
• Range of titers, growth
• Disposables: Spending growth; downstream uses; L&E's; reasons for increasing/ restricting; budget increases; vendor satisfaction
• Batch failure rates & trends
• Selecting a CMO - Problems & solutions
• Quality management & PAT implementation
• Hiring and employment growth
• Supplier growth rates, and much more